Skip to main content
. 2019 Mar 18;2019:7304140. doi: 10.1155/2019/7304140

Table 2.

Glycemic variability among different IA titer groups.

C L H F value/chi-square p value
Ln(MAGE) (mmol/l) 1.36 ± 0.37 1.60 ± 0.35a 1.79 ± 0.50ab 12.610 <0.001
Ln(SDBG) (mmol/l) 0.55 ± 0.37 0.73 ± 0.35a 0.84 ± 0.44a 6.984 0.001
LAGE (mmol/l) 7.49 ± 2.39 9.15 ± 2.72a 10.22 ± 3.75a 9.928 <0.001
MBG (mmol/l) 9.41 ± 2.05 9.49 ± 1.96 9.64 ± 1.82 0.170 0.844
AUC > 13.9 (mmol/l∗min) 0.00 (0.00, 98.25) 7.55 (0.00, 283.48) 173.79 (0.00, 565.20)ab 10.492c 0.005
PT1 (%) 0.00 (0.00, 10.07) 1.39 (0.00, 13.89) 9.10 (0.00, 22.31)ab 8.100c 0.017
AUC < 3.9 (mmol/l∗min) 0.00 (0.00, 0.00) 0.00 (0.00, 2.80) 0.00 (0.00, 17.92)a 6.088c 0.048
PT2 (%) 0.00 (0.00, 0.00) 0.00 (0.00, 1.31) 0.00 (0.00, 2.53)a 5.391c 0.048

Ln: base e logarithm; MAGE: the 24 h mean amplitude of glycemic excursion; SDBG: the standard deviation of 24 h blood glucose; LAGE: the large amplitude of glycemic excursion; MBG: the 24 h mean blood glucose concentration; AUC > 13.9 mmol/l: the incremental area under the curve of plasma glucose > 13.9 mmol/l; AUC < 3.9 mmol/l: the incremental area under the curve of plasma glucose < 3.9 mmol/l; PT1: the percentage of the time spent on glucose concentrations above 13.9 mmol/l; PT2: the percentage of the time spent on glucose concentrations below 3.9 mmol/l. aCompared with the C group (p < 0.05); bcompared with the L group (p < 0.05); cnonparametric test. Data were presented as mean ± SD or median (25th, 75th percentile).